easyNOTES Medical

Endoscopic Treatment of Type 2 Diabetes

Health Tech & Life Sciences
Non Active, Oct 2022 ceased to operate

Company Overview

Snapshot

Founded in January 2011 by Moshe Mizrahi, easyNOTES Medical operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of medical devices. The company ceased operations in October 2022.

Business overview

easyNOTES Medical is a Health Tech & Life Sciences company focused on developing, manufacturing, and marketing medical devices for the endoscopic treatment of Type 2 diabetes. Its core product, EasyByPass, is designed as a simple, non-surgical endoscopic procedure aimed at minimizing complications, reducing patient inconvenience, eliminating the need for hospitalization, and utilizing low-cost resources. The company serves the healthcare industry, specifically targeting gastroenterology, diabetes, and general medical treatment and therapeutics sectors.

Company Intelligence Q&A

What is easyNOTES Medical's primary focus?
easyNOTES Medical is primarily focused on the development, manufacture, and marketing of medical devices for the endoscopic treatment of Type 2 diabetes.
What is the EasyByPass product?
EasyByPass is easyNOTES Medical's proprietary product, which is a simple, non-surgical, endoscopic procedure designed for treating Type 2 diabetes with a low risk of complications and minimal patient inconvenience.
When was easyNOTES Medical founded?
easyNOTES Medical was founded in January 2011.
Who is a co-founder of easyNOTES Medical?
Moshe Mizrahi is a co-founder and Chairman of easyNOTES Medical.
What is the current operational status of easyNOTES Medical?
easyNOTES Medical ceased to operate in October 2022.